×
News
October 28, 2014

Ascertainability Requirement After Carerra v. Bayer Corp.: Class Certification Implications

Strafford

By David Kouba
Find more content tagged:

Stay up-to-date with the latest topics from the firm.

Email Subscriptions RSS Feed (All Perspectives) RSS Feed (News Only)

People

David Kouba
David Kouba
Counsel
Washington, DC
+1 202.942.5626
david.kouba@arnoldporter.com
VCard

Related Articles

October 5, 2018
NJ Supreme Court Ends Accutane Cases in a Significant Opinion Addressing Adequacy of Warning in Pharmaceutical Product Liability Litigation
Advisory
September 7, 2018
Removal in a Snap: Third Circuit Endorses Pre-Service Removals
Advisory
August 24, 2018
INSIGHT: The Prospects for Pharmaceutical Preemption in the Supreme Court
Bloomberg Law

Email Disclaimer

Reject Accept